Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4771 to 4785 of 7685 results

  1. Further evidence to address the uncertainties in the current clinical evidence,including the impact of gammaCore on all treatments and care as well as itslong-term benefits, would be welcome.

    Recommendation ID MTG46/1 Question Further evidence to address the uncertainties in the current clinical evidence,including the impact

    Research recommendation
    Published
    10 February 2020

  2. What specialist management is effective for people whose symptoms do not respond to PPIs despite optimum primary care, or for people whose symptoms return after surgery?

    Recommendation ID CG184/4 Question What specialist management is effective for people whose symptoms do not respond to PPIs despite optimum

    Research recommendation
    Published
    15 November 2019

  3. What is the most effective management strategy for preventing the development of excessive weight gain and metabolic syndrome associated with the use of antipsychotic medication in children and young people?

    Recommendation ID CG155/6 Question What is the most effective management strategy for preventing the development of excessive weight gain

    Research recommendation
    Published
    9 June 2015

  4. What is the clinical and cost effectiveness of psychological intervention alone, compared with antipsychotic medication and compared with psychological intervention and antipsychotic medication combined, in young people with first episode psychosis?

    Recommendation ID CG155/4 Question What is the clinical and cost effectiveness of psychological intervention alone, compared with antipsychotic

    Research recommendation
    Published
    9 June 2015

  5. What are the long-term outcomes, both psychotic and nonpsychotic, for children and young people with attenuated or transient psychotic symptoms suggestive of a developing psychosis, and can the criteria for 'at risk states' be refined to better predict those who will and those who will not go on to develop psychosis?

    Recommendation ID CG155/1 Question What are the long-term outcomes, both psychotic and nonpsychotic, for children and young people with

    Research recommendation
    Published
    9 June 2015

  6. What is the clinical and cost effectiveness for family intervention combined with individual CBT in the treatment of children and young people considered to be at high risk of developing psychosis and their parents or carers?

    Recommendation ID CG155/3 Question What is the clinical and cost effectiveness for family intervention combined with individual CBT in

    Research recommendation
    Published
    9 June 2015

  7. What is the clinical and cost effectiveness of omega-3 fatty acids in the treatment of children and young people considered to be at high risk of developing psychosis?

    Recommendation ID CG155/2 Question What is the clinical and cost effectiveness of omega-3 fatty acids in the treatment of children and

    Research recommendation
    Published
    9 June 2015

  8. What is the clinical effectiveness of clozapine for children and young people with schizophrenia with symptoms unresponsive to antipsychotic medication and psychological treatment combined?

    Recommendation ID CG155/5 Question What is the clinical effectiveness of clozapine for children and young people with schizophrenia with

    Research recommendation
    Published
    9 June 2015

  9. For women who are having medical abortion between 10 +1   and 12 +0  weeks, what is the efficacy and acceptability of expulsion at home compared with expulsion in a clinical setting?

    Recommendation ID NG140/4 Question For women who are having medical abortion between 10 +1 and 12 +0 weeks, what is the efficacy and

    Research recommendation
    Published
    8 November 2019

  10. In adults having elective shoulder joint replacement, what is the relative clinical and cost effectiveness of general anaesthesia, regional anaesthesia, and general combined with regional anaesthesia?

    Recommendation ID NG157/9 Question In adults having elective shoulder joint replacement, what is the relative clinical and cost effectiveness

    Research recommendation
    Published
    10 August 2020

  11. Length of observation period following emergency treatment for anaphylaxis:- For how long should a person who has received emergency treatment for anaphylaxis be observed?

    Recommendation ID CG134/3 Question Length of observation period following emergency treatment for anaphylaxis:- For how long should a person

    Research recommendation
    Published
    9 June 2015

  12. In adults having elective shoulder joint replacement with general anaesthesia, what is the clinical and cost effectiveness of supplementary local infiltration analgesia, a nerve block or regional anaesthesia?

    Recommendation ID NG157/8 Question In adults having elective shoulder joint replacement with general anaesthesia, what is the clinical

    Research recommendation
    Published
    10 August 2020

  13. What is the clinical and cost effectiveness of levothyroxine for people under 65 with symptomatic subclinical hypothyroidism?

    Recommendation ID NG145/7 Question What is the clinical and cost effectiveness of levothyroxine for people under 65 with symptomatic subclinical

    Research recommendation
    Published
    10 February 2020

  14. Lactate level for monitoring severity of shock:- Is lactate monitoring in patients with major trauma clinically and cost effective?

    Recommendation ID NG39/2 Question Lactate level for monitoring severity of shock:- Is lactate monitoring in patients with major trauma

    Research recommendation
    Published
    21 March 2016

  15. What is the clinical and cost effectiveness of levothyroxine (T4) and liothyronine (T3) combination therapy compared with T4 alone for people with hypothyroidism whose symptoms have not responded sufficiently to T4 alone? Does DiO2 polymorphism affect the response to combination therapy with T4 and T3?

    Recommendation ID NG145/1 Question What is the clinical and cost effectiveness of levothyroxine (T4) and liothyronine (T3) combination

    Research recommendation
    Published
    10 February 2020